Stockreport

Beam Therapeutics (BEAM): Among the Stocks That Could 10x Over the Next 5 Years [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF Wainwright reaffirmed its Buy rating and $80 price target on Beam Therapeutics Inc. (NASDAQ:BEAM). The rating follows Beam's fourth-quarter and full-year 2025 results, w [Read more]